AI Article Synopsis
- - Recent research indicates that cell senescence, previously thought exclusive to normal dividing cells, can also happen in cancer cells, especially after treatments like chemotherapy and radiation or due to DNA damage.
- - Inducing senescence in cancer cells may help slow tumor progression, but it can also enhance the invasiveness of certain cancers, highlighting both positive and negative effects.
- - To effectively utilize cancer cell senescence in treatment, it's essential to understand the underlying molecular mechanisms and potential risks involved.
Article Abstract
Cell senescence was considered an attribute of normal dividing cells, which distinguishing them from cancer cells that do not have a division limit. However, recent studies show that senescence could also occur in cancer cells. Cancer cell senescence could occur as a result of chemotherapy, radiation, inhibition of telomerase activity, induction of DNA damage, changes in the tumor microenvironment, regulation of senescence-related proteins, oxidative stress, inflammation, or epigenetic dysregulation. It seems that the induction of senescence in cancer cells could significantly affect the inhibition of tumor progression, but in some types of cancer, it can affect their invasive character. Furthermore, considering the therapeutic implications of this process, it is essential to consider the positive and negative aspects of cancer cell senescence. It is crucial to understand the molecular mechanisms that induce senescence under specific conditions, considering the potential hazards. In the future, the senescence of cancer cells may contribute to using this property in modern cancer treatment strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.33594/000000671 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!